Movement Disorder Clinic
The Movement Disorders group is a unique, Canadian integrated neurology/neurosurgery research and treatment facility that offers a multidisciplinary approach to movement disorders, including speech and language pathology, neuropsychology, and physical therapies.
The Movement disorder Clinic is made up of a number of physicians, nurses, researchers and technologists, working together as a cohesive unit, to bring our patients the highest level of care possible. The clinic treats patients with motion disorders such as Parkinson's disease, Huntington's disease, dystonia, tremor and Tourettes Syndrome.
- Driving Simulator
- Virtual Reality Labs
- Wearable technology for tracking gait
During Academic Half-days neurology residents will study:
- Approach to and differential diagnosis of Parkinsonism
- Therapy of Parkinson’s Disease
- Hyperkinetic movement disorders
- Tics, myoclonus and tremor
- Chorea and Huntington’s disease
- The dystonias
- Acquired and inherited ataxias
- Basic neuroscience: Basal ganglia anatomy and physiology
- Basic neuroscience: Spinocerebellar pathways and disorders
- Neuropathology of key movement disorders
Main Contact: Mandar S. Jog- MD, FRCPC
London Health Sciences Centre
339 Windermere Road
London Ontario Canada
CNS offers training opportunities for residents in movement disorder research. Opportunities for MSc, PhD, and Postdoctoral candidates are also available upon request. Dr. Hebb has acted as a co-supervisor to MSc students researching and cell-based therapies for Parkinson's disease as well as cell autografts as delivery agents for Parkinson's Disease therapeutics.
Dr. Mandar Jog has acted as a primary supervisor and co-supervisor to numerous master’s, doctorate, and postdoctoral researchers. He has advised over research projects on kinematic recordings in home mobility, a training program for navigation in a virtual reality environment, the use of 7 tesla MRS in discriminating Parkinsonism subtypes, and turning strategies in patients with Parkinson's disease.
Dr. Penny MacDonald supervises undergraduate, master’s doctoral, and postdoctoral students on research projects looking at cognition, cognitive deficits, and specific behaviours in Parkinson’s disease patients, as well as various treatment therapies.
If you are interested in conducting movement disorder research or are interested in assisting in ongoing research by our faculty, visit their bio pages for information on their specific research interests and how to get in touch.
Zhou Y, Jenkins ME, Naish MD, Trejos AL. Design and validation of a high-order weighted-frequency fourier linear combiner-based Kalman filter for parkinsonian tremor estimation. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:5893-5896. doi: 10.1109/EMBC.2016.7592069. PubMed PMID: 28269595.
Lutz SG, Holmes JD, Ready EA, Jenkins ME, Johnson AM. Clinical Presentation of Anxiety in Parkinson's Disease: A Scoping Review. OTJR (Thorofare N J). 2016 Jul;36(3):134-47. doi: 10.1177/1539449216661714. Epub 2016 Jul 31. Review. PubMed PMID: 27618849.
Kumar N, Rizek P, Jog M. Movement Disorders in 18p Deletion Syndrome: A Case Report and Review of Literature. Can J Neurol Sci. 2017 Jul;44(4):441-443. doi: 10.1017/cjn.2016.444. Epub 2017 Jan 31. No abstract available. PMID: 28137337.
Page AD, Siegel L, Jog M. Self-Rated Communication-Related Quality of Life of Individuals With Oromandibular Dystonia Receiving Botulinum Toxin Injections. Am J Speech Lang Pathol. 2017 Jun 22;26(2S):674-681. doi: 10.1044/2017_AJSLP-16-0098. PMID: 28654948.
Samotus O, Lee J, Jog M. Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections. PLoS One. 2017 Jun 6;12(6):e0178670. doi: 10.1371/journal.pone.0178670. eCollection 2017. PMID: 28586370.
Glizer D, MacDonald PA. Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014. Parkinsons Dis. 2016;2016:9291713. doi: 10.1155/2016/9291713. Epub 2016 Sep 5. Review. PMID: 27688923.
Welk B, McArthur E, Morrow SA, MacDonald P, Hayward J, Leung A, Lum A. Association Between Gadolinium Contrast Exposure and the Risk of Parkinsonism. JAMA. 2016 Jul 5;316(1):96-8. doi: 10.1001/jama.2016.8096. No abstract available. PMID: 27380348.